← Back to Screener
IM Cannabis Corp. Common Shares (IMCC)
Price$0.41
Favorite Metrics
Price vs S&P 500 (26W)-66.66%
Price vs S&P 500 (4W)126.64%
Market Capitalization$2.29M
All Metrics
Book Value / Share (Quarterly)$1.26
P/TBV (Annual)5.25x
Revenue Growth (3Y)16.64%
Cash Flow / Share (Quarterly)$0.92
Price vs S&P 500 (YTD)166.38%
Gross Margin (TTM)18.58%
Net Profit Margin (TTM)-8.61%
EPS (TTM)$-1.51
10-Day Avg Trading Volume0.01M
EPS Excl Extra (TTM)$-1.51
Revenue Growth (5Y)42.88%
EPS (Annual)$-3.30
ROI (Annual)-45.52%
Gross Margin (Annual)15.64%
Net Profit Margin (5Y Avg)-123.89%
Cash / Share (Quarterly)$0.33
Revenue Growth QoQ (YoY)3.62%
ROA (Last FY)-27.01%
Revenue Growth TTM (YoY)12.68%
EBITD / Share (TTM)$-1.08
ROE (5Y Avg)-273.77%
Operating Margin (TTM)-8.16%
Cash Flow / Share (Annual)$-0.29
P/B Ratio0.59x
P/B Ratio (Quarterly)1.43x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)0.32x
Net Interest Coverage (TTM)-4.00x
ROA (TTM)-11.10%
EPS Incl Extra (Annual)$-3.30
Current Ratio (Annual)0.67x
Quick Ratio (Quarterly)0.59x
3-Month Avg Trading Volume0.01M
52-Week Price Return-84.68%
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$0.55
P/S Ratio (Annual)0.06x
Asset Turnover (Annual)1.38x
52-Week High$9.70
Operating Margin (5Y Avg)-44.27%
EPS Excl Extra (Annual)$-3.30
CapEx CAGR (5Y)-36.80%
Tangible BV CAGR (5Y)-39.61%
26-Week Price Return-66.55%
Quick Ratio (Annual)0.57x
13-Week Price Return-53.88%
Total Debt / Equity (Annual)3.44x
Current Ratio (Quarterly)0.72x
Enterprise Value$12.829
Revenue / Share Growth (5Y)51.97%
Asset Turnover (TTM)1.29x
Book Value / Share Growth (5Y)-24.15%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)6.91x
Pretax Margin (Annual)-23.68%
Cash / Share (Annual)$0.20
Gross Margin (5Y Avg)9.01%
Net Income / Employee (TTM)$-0
EBITDA Interim CAGR (5Y)-31.39%
ROE (Last FY)-201.89%
Net Interest Coverage (Annual)-2.15x
EPS Basic Excl Extra (Annual)$-3.30
P/FCF (TTM)0.39x
Receivables Turnover (TTM)4.70x
EV / Free Cash Flow (TTM)4.54x
Total Debt / Equity (Quarterly)2.96x
EPS Incl Extra (TTM)$-1.51
Receivables Turnover (Annual)5.04x
ROI (TTM)-21.12%
P/S Ratio (TTM)0.06x
Pretax Margin (5Y Avg)-54.14%
Revenue / Share (Annual)$16.85
Tangible BV / Share (Annual)$0.45
Price vs S&P 500 (52W)-84.41%
Year-to-Date Return171.28%
5-Day Price Return96.15%
EPS Normalized (Annual)$-3.30
ROA (5Y Avg)-87.85%
Net Profit Margin (Annual)-19.59%
Month-to-Date Return-40.00%
Cash Flow / Share (TTM)$-0.80
EBITD / Share (Annual)$-2.94
Operating Margin (Annual)-18.94%
LT Debt / Equity (Annual)0.09x
P/CF (TTM)0.78x
ROI (5Y Avg)-175.36%
LT Debt / Equity (Quarterly)0.06x
EPS Basic Excl Extra (TTM)$-1.51
P/TBV (Quarterly)3.28x
P/B Ratio (Annual)1.91x
Inventory Turnover (TTM)6.28x
Pretax Margin (TTM)-11.96%
Book Value / Share (Annual)$1.24
Price vs S&P 500 (13W)-53.90%
Beta2.25x
Revenue / Share (TTM)$12.93
ROE (TTM)-79.48%
52-Week Low$1.75
Analyst Recommendations
Jul 2023
Aug 2023
Sep 2023
Oct 2023
4.14
4.14
4.14
4.14
Industry Peers — Pharmaceutical Preparations(15)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
IMCCIM Cannabis Corp. Common Shares | 0.06x | 12.68% | 18.58% | — | $0.41 |
CRONCronos Group Inc. Common Share | 6.99x | 24.63% | 42.81% | -49.98% | $2.76 |
TLRYTilray Brands, Inc. Common Stock | 0.97x | 3.82% | 27.68% | — | $7.15 |
CGCCanopy Growth Corporation Common Shares | 2.55x | 0.59% | 26.56% | — | $1.20 |
NAGENiagen Bioscience, Inc. Common Stock | 3.01x | 29.95% | 64.28% | — | $4.87 |
USNAUSANA Health Sciences Inc | 0.41x | 5.88% | 78.29% | -37.04% | $20.64 |
SNDLSundial Growers Inc. Common Shares | 0.58x | 2.82% | 27.33% | — | $1.54 |
MDWDMediWound Ltd. | 13.35x | -16.14% | 19.19% | — | $17.35 |
ACBAurora Cannabis Inc. Common Shares | 0.77x | 16.54% | 1.35% | — | $3.72 |
BTMDBiote Corp. Class A Common Stock | 0.46x | -2.52% | 71.46% | -26.84% | $2.24 |
FTLFFitLife Brands, Inc. Common Stock | 1.29x | 1.34% | 37.58% | -20.04% | $8.99 |
About
IM Cannabis Corp is a Canada-based medical cannabis producer operating through Focus Medical Herbs Ltd, which cultivates and supplies medical cannabis products. The company generates the majority of its revenues from medical cannabis sales to Israeli customers, with additional revenues from sales in Germany.